Validation of ICD-10 Codes for Gestational and Pregestational Diabetes During Pregnancy in a Large, Public Hospital.
Journal
Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487
Titre abrégé: Epidemiology
Pays: United States
ID NLM: 9009644
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
1
12
2020
medline:
1
6
2021
entrez:
30
11
2020
Statut:
ppublish
Résumé
The use of billing codes (ICD-10) to identify and track cases of gestational and pregestational diabetes during pregnancy is common in clinical quality improvement, research, and surveillance. However, specific diagnoses may be misclassified using ICD-10 codes, potentially biasing estimates. The goal of this study is to provide estimates of validation parameters (sensitivity, specificity, positive predictive value, and negative predictive value) for pregestational and gestational diabetes diagnosis using ICD-10 diagnosis codes compared with medical record abstraction at a large public hospital in Atlanta, Georgia. This study includes 3,654 deliveries to Emory physicians at Grady Memorial Hospital in Atlanta, Georgia, between 2016 and 2018. We linked information abstracted from the medical record to ICD-10 diagnosis codes for gestational and pregestational diabetes during the delivery hospitalization. Using the medical record as the gold standard, we calculated sensitivity, specificity, positive predictive value, and negative predictive value for each. For both pregestational and gestational diabetes, ICD-10 codes had a high-negative predictive value (>99%, Table 3) and specificity (>99%). For pregestational diabetes, the sensitivity was 85.9% (95% CI = 78.8, 93.0) and positive predictive value 90.8% (95% CI = 85, 97). For gestational diabetes, the sensitivity was 95% (95% CI = 92, 98) and positive predictive value 86% (95% CI = 81, 90). In a large public hospital, ICD-10 codes accurately identified cases of pregestational and gestational diabetes with low numbers of false positives.
Sections du résumé
BACKGROUND
The use of billing codes (ICD-10) to identify and track cases of gestational and pregestational diabetes during pregnancy is common in clinical quality improvement, research, and surveillance. However, specific diagnoses may be misclassified using ICD-10 codes, potentially biasing estimates. The goal of this study is to provide estimates of validation parameters (sensitivity, specificity, positive predictive value, and negative predictive value) for pregestational and gestational diabetes diagnosis using ICD-10 diagnosis codes compared with medical record abstraction at a large public hospital in Atlanta, Georgia.
METHODS
This study includes 3,654 deliveries to Emory physicians at Grady Memorial Hospital in Atlanta, Georgia, between 2016 and 2018. We linked information abstracted from the medical record to ICD-10 diagnosis codes for gestational and pregestational diabetes during the delivery hospitalization. Using the medical record as the gold standard, we calculated sensitivity, specificity, positive predictive value, and negative predictive value for each.
RESULTS
For both pregestational and gestational diabetes, ICD-10 codes had a high-negative predictive value (>99%, Table 3) and specificity (>99%). For pregestational diabetes, the sensitivity was 85.9% (95% CI = 78.8, 93.0) and positive predictive value 90.8% (95% CI = 85, 97). For gestational diabetes, the sensitivity was 95% (95% CI = 92, 98) and positive predictive value 86% (95% CI = 81, 90).
CONCLUSIONS
In a large public hospital, ICD-10 codes accurately identified cases of pregestational and gestational diabetes with low numbers of false positives.
Identifiants
pubmed: 33252439
pii: 00001648-202103000-00015
doi: 10.1097/EDE.0000000000001311
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
277-281Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no funding and conflicts of interest.
Références
DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis. 2014;11:E104.
Battarbee AN, Venkatesh KK, Aliaga S, Boggess KA. The association of pregestational and gestational diabetes with severe neonatal morbidity and mortality. J Perinatol. 2020;40:232–239.
Deputy NP, Kim SY, Conrey EJ, Bullard KM. Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth—United States, 2012–2016. MMWR Morb Mortal Wkly Rep. 2018;67:1201–1207.
Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD. Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark. Diabetologia. 2016;59:1396–1399.
Committee on Practice Bulletins—ObstetricsACOG practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131:e49–e64.
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–1779.
Andrade SE, Moore Simas TA, Boudreau D, et al. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy. Pharmacoepidemiol Drug Saf. 2011;20:1168–1176.
Yasmeen S, Romano PS, Schembri ME, Keyzer JM, Gilbert WM. Accuracy of obstetric diagnoses and procedures in hospital discharge data. Am J Obstet Gynecol. 2006;194:992–1001.
Bowker SL, Savu A, Donovan LE, Johnson JA, Kaul P. Validation of administrative and clinical case definitions for gestational diabetes mellitus against laboratory results. Diabet Med. 2017;34:781–785.
Bowker SL, Savu A, Lam NK, Johnson JA, Kaul P. Validation of administrative data case definitions for gestational diabetes mellitus. Diabet Med. 2017;34:51–55.
Walker RL, Hennessy DA, Johansen H, Sambell C, Lix L, Quan H. Implementation of ICD-10 in Canada: how has it impacted coded hospital discharge data? BMC Health Serv Res. 2012;12:149.
Centers for Medicare & Medicaid Services (CMS)ICD-10. Available at: https://www.cms.gov/Medicare/Coding/ICD10/index?redirect=/ICD10. Accessed August 13, 2020.
Jamieson DJ, Haddad LB. What obstetrician-gynecologists should know about population health. Obstet Gynecol. 2018;131:1145–1152.
Harper LM, Mele L, Landon MB, et al. Carpenter-coustan compared with national diabetes data group criteria for diagnosing gestational diabetes. Obstet Gynecol. 2016;127:893–898.
Kotelchuck M. An evaluation of the Kessner adequacy of prenatal care index and a proposed adequacy of prenatal care utilization index. Am J Public Health. 1994;84:1414–1420.
Kuo CH, Li HY. Diagnostic strategies for gestational diabetes mellitus: review of current evidence. Curr Diab Rep. 2019;19:155.
Hung TH, Hsieh TT. The effects of implementing the International Association of Diabetes and Pregnancy Study Groups criteria for diagnosing gestational diabetes on maternal and neonatal outcomes. PLoS One. 2015;10:e0122261.
ACOG committee opinion no. 736: optimizing postpartum care. Obstet Gynecol. 2018;131:e140–e150.
Dietz P, Bombard J, Mulready-Ward C, et al. Validation of self-reported maternal and infant health indicators in the pregnancy risk assessment monitoring system. Matern Child Health J. 2014;18:2489–2498.